\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Widening/SpreadingFor the call European Excellence Initiative (HORIZON-WIDERA-2023-ACCESS-03-01) 61 proposals have been submitted.
Evaluation results are expected to be communicated in July 2023.
Source: Funding and Tender Portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Digital Europe Cybersecurity Defence
We would like to inform you that the Commission has adopted and published the European Defence Fund Work Programme 2025. The news announcement (with links to the documents and a factsheet) is available on DEFIS website: https://defence-industry-space.ec.europa.eu/european-defence-fund-over-eu1-billion-drive-next-generation-defence-technologies-and... read more
RI Digital, Industry & Space Agro-Food, Environment
The Central European Research Infrastructure Consortium (CERIC-ERIC) is calling for proposals for coordinated access to more than 60 instruments and support laboratories for research in all fields of materials, biomaterials and nanotechnology. A detailed description of the facilities available in CERIC can be found here. Access to CERIC is op... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
